Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thoracic Neoplasms × Sodium Chloride × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 7 Pleural Effusion, Malignant 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Small Cell Lung Carcinoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Limited Stage Small Cell Lung Cancer 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cachexia 1 Brain Neoplasms 1

Interventions

Carboplatin 12 Pemetrexed 6 pembrolizumab 5 Paclitaxel 5 osimertinib 4 atezolizumab 4 entinostat 3 durvalumab 3 Erlotinib Hydrochloride 3 Cisplatin 3 selpercatinib 2 pralsetinib 2 camrelizumab 2 apatinib 2 Radiosurgery 2 Injections 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 taletrectinib 1 sotorasib 1 sintilimab 1 repotrectinib 1 pegylated granulocyte colony-stimulating factor 1 patritumab 1 napabucasin 1 ficlatuzumab 1 exemestane 1 efineptakin alfa 1 cobimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04209868 2024-03-29

ParaSOL

Guy's and St Thomas' NHS Foundation Trust

Phase 2/3 Recruiting

Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡